Testing effectiveness (Phase 2)Study completedNCT00264433What this trial is testingThe Safety and Effects of ADH-1 Given Intravenously as a Single AgentWho this might be right forNeoplasms Adherex Technologies, Inc.
Very early researchLooking for participantsNCT06820424What this trial is testingSafety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid TumorsWho this might be right forCDH17-positive Advanced Solid Tumors 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07529808What this trial is testingPhase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaWho this might be right forGastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more BigHat Biosciences, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT03620643What this trial is testingCrizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid TumoursWho this might be right forLobular Breast CarcinomaGastric CancerTriple Negative Breast Cancer+1 more Royal Marsden NHS Foundation Trust 33
Early research (Phase 1)Study completedNCT00390676What this trial is testingADH 1 in Combination With Carboplatin, or Docetaxel or CapecitabineWho this might be right forNeoplasms Adherex Technologies, Inc.
Early research (Phase 1)Looking for participantsNCT06501183What this trial is testingAnti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid TumorsWho this might be right forCDH17-positive Advanced Malignant Solid Tumors Shanghai Pudong Hospital 17
Very early researchLooking for participantsNCT06937567What this trial is testingCDH17 CAR-T Therapy in Advanced Malignant Solid TumorsWho this might be right forBiliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more Zhejiang University 36